Profile | GDS4284 / 222357_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1969.87 | 83 |
GSM687648 | Patient 402 control | 2402.94 | 86 |
GSM687653 | Patient 403 control | 3328.4 | 90 |
GSM687658 | Patient 404 control | 4872.88 | 93 |
GSM687663 | Patient 411 control | 5057.74 | 93 |
GSM687668 | Patient 422 control | 2910.15 | 88 |
GSM687673 | Patient 424 control | 3980.23 | 92 |
GSM687678 | Patient 425 control | 4826.68 | 93 |
GSM687683 | Patient 427 control | 5782.43 | 95 |
GSM687688 | Patient 428 control | 4589.33 | 93 |
GSM687695 | Patient 441 control | 2750.04 | 89 |
GSM687699 | Patient 443 control | 2712.39 | 88 |
GSM687704 | Patient 444 control | 6025.67 | 95 |
GSM687707 | Patient 448 control | 3815.93 | 91 |
GSM687712 | Patient 449 control | 2920.42 | 88 |
GSM687719 | Patient 450 control | 2876.17 | 89 |
GSM687724 | Patient 451 control | 5166.15 | 94 |
GSM687728 | Patient 452 control | 3033.19 | 89 |
GSM687646 | Patient 401 treated 24h | 4085.09 | 92 |
GSM687649 | Patient 402 treated 24h | 2968.72 | 88 |
GSM687665 | Patient 411 treated 24h | 4919.57 | 93 |
GSM687651 | Patient 402 treated 4 weeks | 3671.02 | 91 |
GSM687667 | Patient 411 treated 4 weeks | 3996.07 | 91 |
GSM687670 | Patient 422 treated 24h | 3137.08 | 89 |
GSM687671 | Patient 422 treated 4 weeks | 2961.19 | 88 |
GSM687654 | Patient 403 treated 24h | 4701.16 | 93 |
GSM687675 | Patient 424 treated 24h | 2652.09 | 88 |
GSM687685 | Patient 427 treated 24h | 4991.75 | 93 |
GSM687656 | Patient 403 treated 4 weeks | 4233.44 | 92 |
GSM687677 | Patient 424 treated 4 weeks | 6214.98 | 95 |
GSM687687 | Patient 427 treated 4 weeks | 5020.5 | 93 |
GSM687692 | Patient 428 treated 4h | 4217.34 | 92 |
GSM687716 | Patient 449 treated 4h | 5317.62 | 94 |
GSM687722 | Patient 450 treated 4h | 3858.42 | 91 |
GSM687680 | Patient 425 treated 24h | 4937.41 | 93 |
GSM687690 | Patient 428 treated 24h | 3150.86 | 89 |
GSM687700 | Patient 443 treated 24h | 3733.46 | 91 |
GSM687705 | Patient 444 treated 24h | 5335.77 | 94 |
GSM687714 | Patient 449 treated 24h | 3551.64 | 90 |
GSM687721 | Patient 450 treated 24h | 2343.08 | 86 |
GSM687682 | Patient 425 treated 4 weeks | 7295.19 | 96 |
GSM687694 | Patient 428 treated 4 weeks | 5768.22 | 94 |
GSM687702 | Patient 443 treated 4 weeks | 3441.31 | 90 |
GSM687718 | Patient 449 treated 4 weeks | 4654.28 | 93 |
GSM687723 | Patient 450 treated 4 weeks | 3087.41 | 89 |
GSM687661 | Patient 404 treated 4h | 3937.67 | 91 |
GSM687710 | Patient 448 treated 4h | 4313.37 | 92 |
GSM687726 | Patient 451 treated 4h | 4944.84 | 93 |
GSM687730 | Patient 452 treated 4h | 3995.85 | 93 |
GSM687660 | Patient 404 treated 24h | 2313.63 | 87 |
GSM687697 | Patient 441 treated 24h | 3089.59 | 90 |
GSM687709 | Patient 448 treated 24h | 2825.64 | 88 |
GSM687725 | Patient 451 treated 24h | 5135.6 | 94 |
GSM687729 | Patient 452 treated 24h | 2006.72 | 85 |
GSM687727 | Patient 451 treated 4 weeks | 9451.35 | 97 |
GSM687731 | Patient 452 treated 4 weeks | 3595.62 | 91 |